| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_89180fcaedb6dc2a53ef6a19499131f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a11fb55bfab4265ffc0ab054c9656e69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_de71996d1afb7567526b22ff2728b0ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9f32d65027926c5863aadb28db6d0ea9 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0541
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36032
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36038 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-36 |
| filingDate |
2013-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2014-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fbe2c9a120551c14031a346520ed6943
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8eb5adbd146fef4ca48287dfb4c0e47f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7aacc73623b081010ff4c59db6e12185 |
| publicationDate |
2014-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8892201-B2 |
| titleOfInvention |
Pharmaceutical agent delivery in a stimulating medical device |
| abstract |
A stimulating medical device comprising a stimulating assembly implantable proximate to nerve cells of a recipient having at least one agent delivery port and a plurality of electrical contacts; an electrical stimulation controller configured to generate electrical stimulation signals for application to a first population of the nerve cells via one or more of the plurality of electrical contacts; a pharmaceutical agent source configured to provide a pharmaceutical agent to the at least one delivery port for application to a second population of the nerve cells; and a pharmaceutical agent controller configured to control one or more of the pharmaceutical agent source and the at least one delivery port to cause selective application of the pharmaceutical agent to the second population of nerve cells. |
| priorityDate |
2006-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |